Amicus Therapeutics ApS

CVR 39359340 · Private limited company (ApS) · Active · Low risk

Amicus Therapeutics ApS is a Private limited company (ApS), founded on , based in København V. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 8 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 425k and a net result of DKK 115k. CEO: Richard Gideon Morris.

Bankruptcy risk for Amicus Therapeutics ApS

0.2%
probability of bankruptcy within 12 months
Low risk

0.2 × the average (1.41%) · higher risk than 49% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO changes in the last year2+ · bankruptcy rate 18.5%2.1×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO< 0.5 yrs · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Share of late annual reports25%–50% · bankruptcy rate 10.6%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Negative equityNo · bankruptcy rate 5.1%0.58×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Return on assets0%–5% · bankruptcy rate 5.8%0.66×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
39359340
Status
Active
Company type
Private limited company (ApS)
Founded
(8 years)
Address
c/o Regus, Rådhuspladsen 16
1550 København V
Municipality
København
Industry
Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 50k
Employees
2 (2018)
Auditor
PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab
Audit opted out
Yes

Warning signs

Annual reports filed late2 of 8
Missing annual reportNo
Negative equityNo
Equity ratio10.0%
Current ratio111%
Moves (last 2 years)0
CEO changes in total8
CEO's previous bankruptcies0
Other companies at the address170
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 1.4mDKK 2.0m
Net profitDKK 115kDKK 16k
EquityDKK 425kDKK 310k
Total assetsDKK 4.2mDKK 3.4m
CashDKK 4.0m–
Short-term debtDKK 3.8m–
Tax owedDKK 51k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025182
1 Jan 2024 – 31 Dec 2024189 Late
1 Jan 2023 – 31 Dec 2023180
1 Jan 2022 – 31 Dec 2022173
1 Jan 2021 – 31 Dec 2021173
1 Jan 2020 – 31 Dec 2020181
1 Jan 2019 – 31 Dec 2019240 Late
23 Feb 2018 – 31 Dec 2018154

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEORichard Gideon MorrisCurrent
CEOJohnny Krogh Hansen
CEOJohn Erik Mattias Bankel
CEOCharlotte Ann Galvin
CEOAna Rogovic
BoardRichard Gideon MorrisCurrent
BoardBrian KeoghCurrent
BoardGraham Stewart Riley MorrisCurrent
BoardJohnny Krogh Hansen
BoardSimon Collins
BoardJasvinder Sarkaria
BoardDetlef Wolff
BoardLori Mochan
BoardJohn Erik Mattias Bankel
BoardAnita Jane Clifford
BoardNicole Ruth Reichman
BoardSteven John Green
BoardCharlotte Ann Galvin
BoardDavid Malcolm Lewis
BoardJessica Alice Stephens-Brown
BoardAna Rogovic
Owner (100%)Amicus Therapeutics UK Ltd.Current
FounderAmicus Therapeutics UK Ltd.Current

The CEOs' other companies

Johnny Krogh Hansen – 1 other companies, of which 1 bankrupt

Address history (0 moves)

c/o Regus, Rådhuspladsen 16, 1550 København V

Employees per year

Number of employees at Amicus Therapeutics ApS per year122018: 22018

Other companies at the same address

Similar companies in København

Questions and answers about Amicus Therapeutics ApS

Has Amicus Therapeutics ApS gone bankrupt?

No, Amicus Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Amicus Therapeutics ApS?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.

Who is the CEO of Amicus Therapeutics ApS?

Richard Gideon Morris is the CEO of Amicus Therapeutics ApS.

Who is the auditor of Amicus Therapeutics ApS?

Amicus Therapeutics ApS most recently used PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.

When was Amicus Therapeutics ApS founded?

Amicus Therapeutics ApS was founded on 23 February 2018.

What is the equity of Amicus Therapeutics ApS?

Equity was DKK 425k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.